Literature DB >> 25405120

Pseudoachalasia: a diagnostic challenge.

Nader Roushan1, Abolfazl Zolfaghari2, Mehrnaz Asadi3, Reza Taslimi4.   

Abstract

Here, we present a case of a 78-year-old man that underwent gastrointestinal endoscopy because of one- month history of dysphagia to liquids and solid foods with accompanying weight loss. On endoscopy, there was distal esophageal stenosis. Multiple biopsies were obtained. Histologic examination of the samples revealed normal tissue. The stenosis was treated by dilatation and abdomino pelvic computed tomography scanning was performed to search for an underlying malignant lesion that showed a mass adjacent to distal esophagus. We did endosonography- guided fine needle aspiration of the mass. It was a squamous cell carcinoma (SCC). Malignancy is a challenging diagnosis in patients with dysphagia and near normal endoscopy. To our knowledge, there are a few reports of SCC to cause it.

Entities:  

Keywords:  Achalasia; Dysphagia

Year:  2014        PMID: 25405120      PMCID: PMC4219883     

Source DB:  PubMed          Journal:  Med J Islam Repub Iran        ISSN: 1016-1430


Introduction

Achalasia is a primary esophageal motility disorder presenting with dysphagia to liqiuds and solid foods. It is usually diagnosed using barium swallow study and manometry. Barium study shows narrowing of esophagogastric junction (EGJ) while manometry shows decreased or absent distal esophageal peristalsis with increased lower esophageal sphincter (LES) pressure and impaired LES relaxation with deglutition. Esophagus appears to be normal on endoscopic examination (1). Pseudoachalasia is characterised by achalasia-like symptoms caused by secondary etiologies. Clinical, radiologic and endoscopic findings resemble those of achalasia but treatment and prognosis are different in these conditions. Therefore, discriminating between these two disorders is important (1-5).

Case report

78-years-old man was admitted to our hospital due to 10-days history of intractable postprandial vomiting. He complained of progressive dysphagia presented initially to solid foods and then to liquids for a month. During this time, he had 15 kilogram weight loss. He smoked for decades and noticed occasional productive cough with no relevant diagnostic work-up. He had history of hypothyroidism after being treated by radio –iodine for the primary hyperthyroidism when he was 60-years-old. However, at the time of presentation, he was in euthyroid state. On clinical examination, he appeared ill and dehydrated. Except for bilateral temporal wasting, the whole clinical examination was normal. Tests of blood and electrolytes showed white blood cell (WBC): 9,700 /µl, Hb: 11.2 g/dl, MCV: 86/fl: Platelet count; 283,000 /µl: ESR; 125 mm/ hour, Na: 137 and K: 3.6 meq/ l. Renal and liver function assays were normal as serum protein electrophoresis study. There was no evidence of hepatobiliary or splenic abnormality on abdominal sonography. On upper endoscopy, esophagus appeared to be diffusely erythematous with multiple white plaques compatible with candidiasis; due to tight LES stenosis, attempts to pass the endoscope into stomach was futile. After dilatation with the Savary dilators, all parts of stomach were visualized that seemed to have normal mucosa. Multiple biopsies were obtained from distal esophagus and proximal stomach (both side of LES); but histologic examination revealed normal mucosa. Abdominal and chest CT scan showed an abnormal soft tissue mass around distal esophagus with a solitary 2 cm pulmonary nodule (SPN) near right lung hilum. His medical records were unavailable to evaluate the growth rate of SPN. On endosonography (EUS), a 42 mm hypoechoic mass was seen at LES extending beneath the mucosa ,involving all layers of esophageal wall albeit without any regional lymph node abnormality. Fine needle aspiration (FNA) guided by EUS was done (Fig.1). Histological study of samples showed a well differentiated squamous cell carcinoma (Fig. 2). We did not evaluate the SPN as he refused to undergo further diagnostic work-up.
Fig. 1
Fig. 2
Fine needle aspiration of the mass during endosonography. Squamous cell carcinoma pathologic preparation obtained during endosonography by Fine needle aspiration. The tumor stage was T3N0M0. Therefore, he received chemo radiotherapy with platinium-based regimen. Thereafter, dysphagia improved significantly. Unfortunately, he died six months after treatment due to a heart attack.

Discussion

Motility type dysphagia defined by difficult passage of both liquids and solid foods to stomach is a diagnostic challenge to physicians. The differential diagnosis includes a wide spectrum of various disorders. At one end are benign motility disorders such as diffuse esophageal spasm, hypertensive LES and achalasia, and at the other extreme, are ominous malignant cancers mimicking achalasia. Dysphagia to both liquid and solid foods that is not due to primary neuronal disease and instead is due to secondary malignant or non-malignant causes is called pseudoachalasia; nonmalignant diseases include pancreatic pseudocyst, amyloidosis, sarcoidosis, neurofibromatosis, aortic aneurysm, juvenile Sjogren syndrome, chronic idiopathic intestinal pseudo obstruction, familial glucocorticoid deficiency syndrome, and a few surgeries (vagotomy, bariatric, Nissen fundoplication) (2, 5-12). Esophagogastric junction adenocarcinoma comprises the most common malignant cause of pseudoachalasia (2, 3, 13); the others include cancers of pancreas, esophagus, lung, kidney, hepatobililary, lymphoma and mesothelioma (2). Malignant neoplasms comprise 4% of achalasia-like syndromes (3, 13). Dysmotility in achalasia is caused by unrecognized causes that destroy distal esophageal and LES inhibitory neurons; these cause LES muscle contraction with no relaxation in deglutition. Suggested mechanisms for pseudoachalasia include encircling and compressing LES by tumor, infiltration of myentric plexus branches or vagus nerves, and paraneoplastic neuropathy without direct infiltration of nerves by malignant cells (2, 5). Standard treatment of achalasia, including balloon dilatation and surgical myotomy are ineffective and even dangerous for pseudoachalasia and delays timely diagnosis of malignant neoplasm (1-3, 5). So every attempts should be done to reach correct diagnosis. Endoscopy is the first diagnostic modality in a patient with new onset dysphagia (14); it detects structural esophageal and gastric abnormalities; especially tumors. In achalasia-like syndrome, it may show mass, nodularity, irregular mucosa or ulcer, pointing to pseudoachalasia rather than achalasia (1, 15). Even in normal appearing mucosa, difficult passage of endoscope through LES suggests peudoachalasia in contrast to achalasia that endoscope can be passed with subtle pressure through LES (1, 2). In the case of normal appearing esophagus on endoscopy and new onset dysphagia, the physician must be vigilant to the presence of an underlying malignant lesion, especially when the patient is old, and there is significant weight loss (1, 13, 16). In such circumstances, CT scan and EUS are helpful diagnostic tools. CT scan may show asymmetric wall thickening of distal esophagus and even a well-defined mass (2, 5). EUS would reveal more information as it precisely defines esophageal wall layers and any abnormal tissue; EUS also can be used for tissue acquisition by FNA, when endoscopic biopsies are inconclusive (4, 17, 18). In the literature, squamous cell carcinoma as a cause of pseudoachalasia has been shown to be derived from esophagus, liver, lung and uterine cervix (1, 2, 5, 13). Our case was probably due to a primary lung squamous cell cancer with metastasis to distal esophagus because he was smoker and had a SPN in right lung.

Conclusion

Pseudoachalasia should be in mind when approaching to every patient with suspected achalasia and especially alarm signs should be questioned; on the other hand, it should be kept in mind that simple mucosal biopsy do not exclude pseudoachalasia and in suspected patients further work up such as CT scan and EUS may be warranted.
  17 in total

1.  [Pseudoachalasia and secondary amyloidosis in a patient with rheumatoid arthritis].

Authors:  J M López-Cepero Andrada; J Jiménez Arjona; A Amaya Vidal; J Rubio Garrido; C Navas Relinque; M J Soria de la Cruz; A Benítez Roldán
Journal:  Gastroenterol Hepatol       Date:  2002 Jun-Jul       Impact factor: 2.102

2.  Endoscopic ultrasonography in achalasia.

Authors:  J Devière; F Dunham; F Rickaert; N Bourgeois; M Cremer
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682

3.  [Pseudoachalasia due to amyloidosis treated by botulinum toxin].

Authors:  M Benjelloun; C-L Peng; F Héritier; M Roger
Journal:  Rev Med Interne       Date:  2006-12-05       Impact factor: 0.728

4.  Pseudoachalasia secondary to metastatic breast carcinoma.

Authors:  J M Paulsen; G C Aragon; M A Ali; F J Brody; M L Borum
Journal:  Dig Dis Sci       Date:  2009-05-07       Impact factor: 3.199

5.  Education and Imaging. Gastrointestinal: pseudoachalasia caused by a lower esophageal stromal tumor.

Authors:  A Mohamed
Journal:  J Gastroenterol Hepatol       Date:  2009-06       Impact factor: 4.029

Review 6.  Primary achalasia: analysis of endoscopic ultrasonography features with different instruments.

Authors:  J Devière
Journal:  Gastrointest Endosc Clin N Am       Date:  1995-07

7.  Pseudoachalasia and laparoscopic gastric banding.

Authors:  Sabine Roman; Peter J Kahrilas
Journal:  J Clin Gastroenterol       Date:  2011-10       Impact factor: 3.062

8.  Comparison of pseudoachalasia and achalasia.

Authors:  P J Kahrilas; S M Kishk; J F Helm; W J Dodds; J M Harig; W J Hogan
Journal:  Am J Med       Date:  1987-03       Impact factor: 4.965

9.  Neurofibromatosis of the esophagus.

Authors:  Giuseppe S Sica; Vejay Sujendran; Brian Warren; Nicholas D Maynard
Journal:  Ann Thorac Surg       Date:  2006-03       Impact factor: 4.330

10.  Pseudoachalasia occurring after laparoscopic Nissen fundoplication and crural mesh repair.

Authors:  Luigi Bonavina; Davide Bona; Greta Saino; Claudio Clemente
Journal:  Langenbecks Arch Surg       Date:  2007-05-26       Impact factor: 3.445

View more
  2 in total

1.  Burkitt's Lymphoma of the Gastrohepatic Omentum: A Malignant Presentation of Pseudoachalasia.

Authors:  Eric Omar Then; Andrew Ofosu; Prashanth Rawla; Tagore Sunkara; Sriharsha Dadana; Andrea Culliford; Vinaya Gaduputi
Journal:  Case Rep Gastrointest Med       Date:  2019-01-13

Review 2.  Peroral Endoscopic Myotomy as a Novel Treatment for Achalasia: Patient Selection and Perspectives.

Authors:  Pravallika Chadalavada; Prashanthi N Thota; Siva Raja; Madhusudhan R Sanaka
Journal:  Clin Exp Gastroenterol       Date:  2020-11-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.